GSK2801 - Bromodomain BAZ2A/B Inhibitor. CAS# 1619994-68-1 size:2 mg solid is a highly potent and

is a highly potent and selective inhibitor of SIRT1 with an IC50 ~98 nM

(2012) Genes Dev

PO) significantly augments plasma insulin levels and reduces fasting hyperglycemia in male Zucker diabetic fatty rats

23(1):131-8

GSK2801 - Bromodomain BAZ2A/B Inhibitor. CAS# 1619994-68-1 size:2 mg solid is a highly potent andGSK2801, CAS No. 1619994 68 1, is a potent, selective and cell permeable inhibitor of the bromodomain BAZ2A and BAZ2B. It binds to BAZ2 bromodomains with dissociation constants (KD) of 136 and 257 nM for BAZ2B and BAZ2A, respectively. Crystal structures of GSK2801 demonstrated a canonical acetyl lysine competitive binding mode. It does not interact with the bromodomains of BRD4(BD1), CREBBP, TRIM24 TIF1, PB1(BD5), PCAF, or ATAD2. A pharmacokinetic